Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice Carla Boquimpani, Fernanda Salles Seguro, Gustavo Henrique Romani Magalhães, Ingrid Luise Soares Pinto, Israel Bendit, Jaisson André Pagnoncelli Bortolini, Katia Borgia Barbosa Pagnano, Renato Centrone, Vaneuza Funke

Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies Tomasz Sacha, Katarzyna Krawczyk

Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management Carla Maria Boquimpani, André Neder Ramires Abdo, Denise Pires Martins, Luciana Britto de Abreu Lima, Mayde Seadi Torriani, Israel Bendit